Tempo Scan share sale increased to $229 million

Robust demand from high-quality institutions allows the majority owner to sell more shares than planned in Tempo Scan, an Indonesian pharmaceutical and consumer products company.

Tempo Scan share sale increased to $229 million

The controlling shareholder of Indonesia’s Tempo Scan Pacific has raised Rp2.12 trillion $229 million from the sale of existing shares through a fully marketed transaction that was enlarged beyond the previously announced deal size, pushing the free-float above 20%.

Bogamulia Nagadi ended up selling a total of 800 million shares in the pharmaceutical, consumer products and cosmetics company, which is 18.5% more than the initial base deal and upsize option combined. The deal was also...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: placement | pharmaceutical | consumer | hsbc

Print Edition

FinanceAsia Print Edition